Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

GMI LABORATORIES LLC

NPI: 1154811917 · NORTH HOLLYWOOD, CA 91607 · Clinical Medical Laboratory

$96K
Total Medicaid Paid
48,235
Total Claims
45,007
Beneficiaries
30
Codes Billed
2019-05
First Month
2023-10
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 1,769 $5K
2022 10,050 $55K
2023 36,416 $36K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87798 3,606 3,273 $29K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3,064 2,906 $18K
87640 3,348 3,028 $8K
87481 2,702 2,514 $6K
87150 2,602 2,466 $6K
80307 1,559 1,529 $4K
87502 3,120 2,890 $4K
87634 3,165 2,939 $3K
87529 3,098 2,866 $3K
0100U 138 138 $2K
87581 3,361 3,113 $2K
87541 3,178 2,936 $2K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 435 425 $1K
87651 1,824 1,761 $1K
87486 3,351 3,105 $1K
87653 2,691 2,505 $1K
87498 3,141 2,900 $1K
87801 102 95 $534.33
87426 1,107 1,047 $490.36
87631 107 97 $488.96
0097U 177 175 $363.04
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 978 945 $305.80
87641 204 196 $266.03
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 380 373 $245.00
87652 120 116 $235.01
87500 120 116 $197.48
83525 13 13 $21.26
83735 12 12 $12.47
80305 510 506 $0.00
87633 22 22 $0.00